Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 1

1(12.5%)

8Total

N/A(7)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07441928Not ApplicableRecruiting

Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients

Role: collaborator

NCT07209969Not ApplicableActive Not Recruiting

CBT-I in Adolescents With ADHD

Role: collaborator

NCT07028346Not ApplicableNot Yet Recruiting

Exploring Substance Use, Sleep Disturbances and Reward Sensitivity

Role: lead

NCT06351930Not ApplicableRecruiting

CBT for Insomnia in Adolescents With ADHD

Role: collaborator

NCT00919620Not ApplicableCompleted

Stage-specific Case Management for Early Psychosis

Role: collaborator

NCT01536756Not ApplicableCompleted

Effectiveness of a Structured Physical Rehabilitation Program for Chinese Patients With Depressive Disorders

Role: collaborator

NCT01780116Phase 1Completed

Effectiveness of Adherence Therapy for Schizophrenia

Role: collaborator

NCT01423669Unknown

Epidemiology Study of Psychosis

Role: collaborator

NCT01202357Not ApplicableUnknown

Optimal Duration of Early Intervention for Psychosis

Role: collaborator

All 9 trials loaded